Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Mayo Clinic
Mayo Clinic
Alliance for Clinical Trials in Oncology
Swiss Cancer Institute
M.D. Anderson Cancer Center
City of Hope Medical Center
Technical University of Munich